PlainRecalls
FDA Drug Moderate Class II Terminated

KETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3796-01 ---- ALSO labeled under NOVAPLUS label NDC 0409-3796-49

Reported: April 15, 2015 Initiated: January 23, 2015 #D-0483-2015

Product Description

KETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3796-01 ---- ALSO labeled under NOVAPLUS label NDC 0409-3796-49

Reason for Recall

Crystallization

Details

Recalling Firm
Hospira Inc.
Units Affected
HOSPIRA = 4,339,500 vials. NOVAPLUS = 341,100 vials
Distribution
U.S. Nationwide and International: Guam and Singapore.
Location
Lake Forest, IL

Frequently Asked Questions

What product was recalled?
KETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3796-01 ---- ALSO labeled under NOVAPLUS label NDC 0409-3796-49. Recalled by Hospira Inc.. Units affected: HOSPIRA = 4,339,500 vials. NOVAPLUS = 341,100 vials.
Why was this product recalled?
Crystallization
Which agency issued this recall?
This recall was issued by the FDA Drug on April 15, 2015. Severity: Moderate. Recall number: D-0483-2015.